Home › NDC Lookup › Drug shortages › Ivermectin Tablet

Ivermectin Tablet shortage

Ivermectin Tablet is currently listed in shortage by the FDA. The FDA lists 1 affected product. This page was last refreshed from FDA data on Oct 1, 2026.

To Be Discontinued ⚠ Supply risk: High Anti-Infective 1 product 2 days First posted Sep 29, 2026 Updated Sep 29, 2026
Here’s the bottom line

Merck Sharp & Dohme is stopping its ivermectin 3 mg tablets, with the change taking effect October 31, 2026. Other manufacturers — including Edenbridge Pharmaceuticals, A-S Medication Solutions, and NuCare Pharmaceuticals — still list ivermectin 3 mg tablets, including the brand Stromectol, as available sources.

Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).

Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →
1
Affected NDCs
1
Reporting manufacturers
0/1
Reporting mfrs supplying
0/1
Affected strengths supplied
2
Days in shortage
39
Medicaid Rx (2026)
Source: FDA Drug Shortages Database API (openFDA). Last refreshed Oct 1, 2026 · yesterday

What’s in shortage — at a glance

These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Ivermectin Tablet. Other makers that haven’t reported a problem are shown in the green card below.

Availability of affected NDCs
From the FDA shortage report
1 NDCs
To be discontinued 1
Affected strengths still supplied
Among manufacturers reporting this shortage
0/1 strengths
No supply 1
FDA-reporting manufacturers with supply
Among manufacturers reporting this shortage
0/1 makers
No supply 1
✓ Other manufacturers not reporting a shortage
Still-marketed Ivermectin Tablet from companies that have not filed an FDA shortage — these are not counted in the figures above. Stock can still vary by pharmacy.
Merck Sharp & Dohme LLC Edenbridge Pharmaceuticals LLC. A-S Medication Solutions NuCare Pharmaceuticals,Inc. Advagen Pharma Ltd DR. REDDY'S LABORATORIES, INC.
Plus 13 alternative dosage forms of Ivermectin.
See all other options & details →
Shortage timeline
  1. Sep 29, 2026
    Currently in shortage
    1 of 1 product affected.
  2. Sep 29, 2026
    First reported to the FDA
    1 product first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

What exactly is on backorder — by manufacturer

Manufacturer: Merck Sharp & Dohme LLC 📞 800-672-6372 1 NDC click to expand
Status NDC / product Strength Availability Related information Reason
To Be Discontinued STROMECTOL, Tablet, 3 mg (NDC 0006-0032-01) NDC 00006-0032-01 — — Product will be discontinued on 10/31/2026 —

These rows are manufacturer reports to the FDA for Ivermectin Tablet — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Ivermectin Tablet? options further down this page.

Why is Ivermectin Tablet in shortage?

Merck Sharp & Dohme (the maker of the brand-name version called Stromectol) has let the FDA know that they plan to permanently stop making their 3 mg ivermectin tablet — specifically the package under NDC 0006-0032-01 — as of October 31, 2026. That's the reason this product appears on the FDA shortage list.

It's worth knowing that Merck didn't share a specific public reason why they made this decision — just the discontinuation date. This also only reflects what Merck has reported to the FDA about their own product, so it's about this one particular manufacturer and package, not a statement about ivermectin tablets as a whole.

Based on the manufacturer-reported reason(s) and notes on file with the FDA for Ivermectin Tablet, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.

What should I do if I take Ivermectin Tablet?

Ivermectin tablets are currently on the FDA shortage list, and I want to walk you through what that means for the strength you take.

The affected product is the 3 mg tablet. According to the reported data, this is the only strength on this record, and it does not have an available source right now. The manufacturer that filed this report, Merck Sharp & Dohme (which makes Stromectol), has noted that its 3 mg tablet is planned to be discontinued on 10/31/2026. Because this is listed as a discontinuation rather than a temporary delay, this particular supply problem may be permanent for that maker.

That said, this report reflects only one manufacturer. Other companies still list the same medicine — ivermectin 3 mg tablets — so your pharmacy may be able to source one of those, though it may not be sitting on the local shelf.

Here is what I suggest, in order:

  • Do not stop, skip, or change your dose on your own.
  • Ask your pharmacy to check wholesalers and other manufacturers for ivermectin 3 mg tablets from another maker.
  • If your exact product cannot be found, ask your prescriber or pharmacist about a clinician-chosen option.

Manufacturer contact numbers are listed on this page for reference; pharmacies usually handle those calls. This is general national information and may not match your local stock.

See “Where else can I get Ivermectin Tablet?” below ↓ The same medicine from manufacturers not reporting a shortage, alternative dosage forms, and therapeutic equivalents with pricing.
If you are a patient:
  • Don’t stop or change the medication on your own — talk to your prescriber first.
  • If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
  • Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
  • Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Keep reading
Our full Ivermectin guide

Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.

Read the Ivermectin guide →

Where else can I get Ivermectin Tablet?

FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Ivermectin Tablet is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Same medicine, other manufacturers (not reported short)

Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:

ProductStrengthForm / routeManufacturerNDC
Stromectol IVERMECTIN 3 mg/1 Tablet · Oral Merck Sharp & Dohme LLC 00006-0032-20
Ivermectin IVERMECTIN 3 mg/1 Tablet · Oral Edenbridge Pharmaceuticals LLC. 42799-0806-01
Ivermectin IVERMECTIN 3 mg/1 Tablet · Oral A-S Medication Solutions 50090-5587-00
Ivermectin IVERMECTIN 3 mg/1 Tablet · Oral NuCare Pharmaceuticals,Inc. 68071-2242-03
Ivermectin IVERMECTIN 3 mg/1 Tablet · Oral Advagen Pharma Ltd 72888-0206-09
Ivermectin IVERMECTIN 6 mg/1 Tablet · Oral Advagen Pharma Ltd 72888-0207-09
Ivermectin IVERMECTIN 3 mg/1 Tablet · Oral DR. REDDY'S LABORATORIES, INC. 75907-0167-21

Alternative dosage forms of Ivermectin

A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:

Therapeutic equivalents & pricing 11 productsclick to expand

Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.

ProductManufacturerPackageNADAC $/unitAB ratingAvailability
Ivermectin 3 mgNDC 42799-0806-01 Edenbridge 20 tablets $1.994 save 55% AB Availability likely
Ivermectin 3 mgNDC 75907-0167-21 DR. 20 tablets $1.994 save 55% AB Availability likely
Stromectol 3 mgNDC 00006-0032-01 Merck 20 tablets $4.459 AB Availability likely
Ivermectin 3 mgNDC 27241-0293-73 Ajanta 20 tablets — AB FDA listed
Ivermectin 3 mgNDC 50090-5587-00 A-S 20 tablets — AB FDA listed
Ivermectin 3 mgNDC 68071-2242-03 NuCare 20 tablets — AB FDA listed
Ivermectin 3 mgNDC 70771-1731-03 Zydus 20 tablets — AB FDA listed
Ivermectin 3 mgNDC 72578-0223-83 Viona 20 tablets — AB FDA listed
Ivermectin 3 mgNDC 72888-0206-09 Advagen 100 tablets — AB FDA listed
Ivermectin 3 mgNDC 76420-0619-20 Asclemed 20 tablets — AB FDA listed
ivermectin 3 mgNDC 42806-0017-20 EPIC 20 tablets — AB FDA listed

Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.

Other drugs in the same treatment class

These are different medicines — not other versions of Ivermectin Tablet — that fall in the same broad treatment class (anthelmintics) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.

Identity & classification

GCN Seq No 043094
GCN 93064
HICL code 010933
Ingredient (HICL) Ivermectin
HIC1 code W
Therapeutic class — broad (HIC1) Anti-Infecting Agents
HIC2 code W4
Therapeutic class — intermediate (HIC2) Antiparasitics
HIC3 code W4L
Therapeutic class — specific (HIC3) Anthelmintics
AHFS code 08:08.00.00
AHFS class Anthelmintics
FDB label name STROMECTOL 3 MG TABLET
FDB brand name Stromectol
Legend status F — Federal legend — prescription drug or device
GPI-1415000007000310
GPI classStromectol
Where does this data come from?
Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Other anti-infective shortages

Ivermectin Tablet shortage FAQs

Is Ivermectin Tablet in shortage?
Yes — the FDA currently lists Ivermectin Tablet in shortage (status: “To Be Discontinued”, first reported Sep 29, 2026). 1 of 1 product is affected. This is national, manufacturer-reported data, so your pharmacy may still have stock.
Which products are affected?
STROMECTOL, Tablet, 3 mg (NDC 0006-0032-01) (NDC 00006-0032-01). The full per-NDC list (availability, manufacturer and status) is in the table above — each NDC links to its own page.
When will Ivermectin Tablet be available again?
The FDA does not publish a guaranteed restock date, and no estimated-recovery note is on file. Availability can change daily — confirm with your pharmacy.
Can I still get Ivermectin somewhere?
Other manufacturers (Merck Sharp & Dohme LLC, Edenbridge Pharmaceuticals LLC., A-S Medication Solutions and others) still market it and have not reported a shortage. 13 alternative dosage forms of Ivermectin are also listed. See “Where else can I get Ivermectin Tablet?” above — stock still varies by pharmacy.
What should I do if I take Ivermectin Tablet?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another manufacturer or a different strength/package size, and ask your prescriber about a long-term plan before your supply runs out.

Still have a question about the Ivermectin Tablet shortage?

Ask a pharmacist about this shortage →
How to read the Supply-Risk rating
Low (1–2)Multiple manufacturers still supplying and most strengths or pack sizes sourceable.
Medium (3)Some constraint — fewer suppliers or a notable share of NDCs unavailable.
High (4–5)Down to a single source, most strengths or pack sizes unsourceable, or a long-running outage.
Where does this data come from?
Shortage records come from the FDA Drug Shortages Database API via openFDA (/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.
Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD.
← Back to all current drug shortages